Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Multiple Sclerosis Centers of Excellence

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Consortium of Multiple Sclerosis Centers 2018 Annual Meeting

The Consortium of Multiple Sclerosis Centers (CMSC) is dedicated to improving and advancing the standards of care for those living with MS through educational programs, pilot research projects, and mentoring. The 2018 Annual Meeting in Nashville, TN, May 30 - June 2, 2018, was a huge success with over 2,100 attendees registering on-line as well as 100's more registering on-site.CMSC VA Business Meeting

MSCoE had many visitors to our booth in the expo area, wanting to know more about MSCoE programs and services, as well as MS care within VA. Our Business Meeting was well attended, with updates provided by representatives from the National MS Society, Paralyzed Veterans of America, and CMSC. Below is a list of presentations, platforms, and abstracts that MSCoE staff and MS Regional and Support Program staff were involved with. To view posters, visit CMSC Abstracts and CMSC Posters.

PresentationsMichelle Cameron presenting at CMSC

Immune Insights into MS from EAE: Musing of a MD (mouse doctor)

  • Gregory Wu (MS Regional Program Director, St. Louis, MO)

Obesity, Vascular Disease Risk Factors and MS: Impact, Current Management and Future Directions

  • Jodie Haselkorn (Director, MSCoE-West)
  • Vijayshree Yadav (Assistant Director Clinical Care, MSCoE-West)
  • Michael Lane (VA Physician Fellow, MSCoE-West)
  • Jonathan Purnell
  • Anne CrossVJ Yadav Presenting at CMSC

Real World Risks of Complex Therapies

  • Joseph Berger
  • Eric Williamson (MS Regional Program Director, Philadelphia, PA)

Summary of the 7th International Symposium on Gait and Balance in MS

  • Michelle Cameron (Co-Director and Associated Director Research, MSCoE-West)
  • Kathleen Zackowski
  • Kyle Eveland-DeWan

Using Big Data: Prevalence and Morbidity Outcomes

  • Mitchell Wallin (Director, MSCoE-East)
  • William Culpepper (Associate Director Informatics and Epidemiology, MSCoE-East)

Platforms

Clinical Cannabis Interprofessional Education: Program Development and Provider Knowledge

  • Kim Jones
  • Joseph Bubalo
  • Colin Roberts
  • Michelle Cameron (Co-Director and Associated Director Research, MSCoE-West)

Posters

17-Year Experience of Treating MS with Intramuscular Interferon Beta-1a Twice a Week

  • Robert Baumhefner (MS Regional Program Director, Los Angeles, CA)

Association of 30-Day Continuity of Care with Outcomes in MS

  • Kanika Sharma
  • Yubo Gao
  • Junlin Liao
  • John Kamholz
  • Frank Bittner (former VA Physician Fellow, MSCoE-West; VA Neurologist, Iowa City, IA)

Derivation and Validation of a Predictive Model for 30-Day Readmission Risk in Patients with MS

  • Kanika Sharma
  • Yubo Gao
  • Junlin Liao
  • John Kamholz
  • Frank Bittner (former VA Physician Fellow, MSCoE-West; VA Neurologist, Iowa City, IA)
  • Piyush Kalakoti

Effect of Chronic Medical Conditions in Veterans with MS on Long-term Disability

  • Meheroz Rabadi (MS Regional Program Director, Oklahoma City, OK)

Evaluation of a Spasticity Management Program for People with MS: Study Protocol

  • Cinda Hugos (VA Research Principal Investigator, Portland, OR)
  • Michelle Cameron (Co-Director and Associated Director Research, MSCoE-West)

Impact of Ocrelizumab Treatment on Progressive Multifocal Leukoencephalopathy Risk Biomarkers

  • Eric Williamson (MS Regional Program Director, Philadelphia, PA)
  • Jakob Dobrowolski

MS Clinical Video Telehealth (MS-CVT) for Neurology Care and Telerehabilitation in the Home

  • Amy Kunce
  • Jina Fritz
  • Jodie Haselkorn (Director, MSCoE-West)
  • Mitchell Wallin (Director, MSCoE-East)

NMDA R Encephalitis Management: To Be Aggressive or Cautious, Investigating a Standardized Treatment Regimen

  • Michael Lane (VA Physician Fellow, MSCoE-West)
  • Anna Orban
  • Vijayshree Yadav (Assistant Director Clinical Care, MSCoE-West)

Phosphorylated SIRT1 as a Biomarker of Relapse and Response to Treatment with Glatiramer Acetate in MS

  • Jonathan Ciriello
  • Alexandru Tatomir
  • Daniel Hewes
  • Vinh Nguyen
  • Walter Royal (former Associate Director Research, MSCoE-East) 
  • Violeta Rus
  • Horea Rus (VA Neurologist, Baltimore, MD)

Predictors of Mortality in Veterans with MS in an Outpatient Setting

  • Meheroz Rabadi (MS Regional Program Director, Oklahoma City, OK)
  • Christopher Aston

Transition from Natalizumab to Dimethyl Fumarate in MS Patients: Clinical and MRI Outcomes

  • Mark Waheed
  • John Rose
  • Ka-ho Wong
  • Stacey Clardy (VA Neurologist, Salt Lake City, UT)
  • Julia Klein
  • M. Mateo Paz Soldan (MS Regional Program Director, Salt Lake City, UT)
  • Lucy Dewitt
  • John Steffens

Vascular Disease Risk Factors and MS Progression: A Study of Brain Metabolism

  • Allison Fryman (VA Research Coordinator, Portland, OR)
  • Michael Lane (VA Physician Fellow, MSCoE-West)
  • Manoj Sammi
  • Frank Bittner (former VA Physician Fellow, MSCoE-West; VA Neurologist, Iowa City, IA)
  • Dennis Bourdette (retired Co-Director, MSCoE-West)
  • William Rooney
  • Vijayshree Yadav (Assistant Director Clinical Care, MSCoE-West)

What MS Veterans Want to Know About MS: Subject and Formats

  • Lynda Hillman (Clinical Nursing Director, MSCoE-West)